<DOC>
	<DOCNO>NCT03079674</DOCNO>
	<brief_summary>The burden non-disabling ischemic cerebrovascular event ( NICE ) significantly increase . In order achieve accurate risk stratification effective treatment , develop new diagnostic , therapeutic , prognostic strategy indispensable . Chinese registry NICE national multi-center prospective study aim explore epidemiology , new biomarkers , risk factor prognostic model .</brief_summary>
	<brief_title>China Registry Non-disabling Ischemic Cerebrovascular Events</brief_title>
	<detailed_description>The pathophysiology transient ischemic attack ( TIA ) minor stroke continuous progression . TIA minor stroke exhibit common substantial risk factor early stroke recurrence epidemiological characteristic . Since TIA minor stroke may leave impermanent mild neurological deficit , term non-disabling ischemic cerebrovascular disease ( NICE ) . The result China Chronic Disease Risk Factor Surveillance ( CCDRFS ) 2010 show age-standardized prevalence TIA 2.27 % . Estimated 23.9 million people may experience TIA China . The TIA knowing-rate approximately 3.08 % Chinese adult , 5.02 % receive treatment 4.07 % receive guideline recommend therapy . The Second China National Stroke Registry ( CNSR-II ) indicate minor stroke account 42.23 % hospitalized patient ischemic stroke , much high show CNSR-I ( 2007-2008 ) . Thus , imperative develop new strategy improve diagnosis , risk prediction appropriate management NICE . NICE attractive research area globally . According large quantity NICE patient China low standardize therapeutic rate , awareness NICE largely insufficient . The purpose present study establish multi-center national prospective database NICE , include clinical information biological sample library , explore epidemiology , new biomarkers , risk factor , prognostic model .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<criteria>1 . â‰¥18 year old 2. elapse time last episode registry &lt; 48 hour 1. patient refuse participate research , patient fail complete followup protocol . 2. patient malignant tumor , patient severe liver kidney disease , whose life expectancy le 1 year . 3. patient receive endovascular thrombolytic therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>transient Ischemic Attack</keyword>
	<keyword>minor Stroke</keyword>
	<keyword>non-disabling ischemic cerebrovascular event</keyword>
	<keyword>biomarker</keyword>
	<keyword>epidemiology</keyword>
	<keyword>prognosis</keyword>
</DOC>